Stay updated with the latest biopharmaceutical news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on biopharmaceutical topics.
Bengaluru: Global biopharmaceutical company AstraZeneca is investing Rs166 crore to expand its Bengaluru operations, creating 400 new jobs. The upgraded facility will support around 1,300 employees and enhance the company's capabilities in AI-driven R&D, global business services, IT, and digital health, strengthening its presence in India.This investment follows AstraZeneca's recent expansion of its Global Innovation and Technology Centre (GITC) in Chennai. The company's workforce in India will ...Read More >
Mumbai: Dr Reddy's Laboratories has entered into a collaboration with Reykjavik, Ireland-based biotech company Alvotech to co-develop, manufacture and commercialise a biosimilar version of blockbuster cancer drug Keytruda for the global markets. Keytruda (generic name is pembrolizumab), manufactured and marketed by Merck & Co, is the most successful medicine, recording worldwide sales of $29.5 billion in 2024. It is used to treat multiple forms of cancer. Under the terms of the agreement, both ...Read More >
Biopharmaceutical company Boehringer Ingelheim has launched a next generation poultry vaccine for Marek's disease in the country. The product represents a breakthrough in vaccine engineering and recommended for in-ovo vaccination of 18 to 19-day-old embryonated chicken eggs and one-day old chickens to protect against the virulent Marek's disease, the company said in a release on Tuesday (November 26, 2024). The vaccine offers enhanced protection through an innovative controlled attenuation pro ...Read More >
, /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company received marketing authorization in from National Medical (TASE:PMCN) Products Administration (NMPA) for the first domestically developed trophoblast cell-surface antigen 2 (TROP2)-directed antibody"drug conjugate (ADC) sacituzumab tirumotecan (sac-™T, formerly SKB264/MK-2870) for adult patients with unresectable locally advanced or metastatic triple negative breast cancer (TNBC) who ha ...Read More >
New Delhi: Biologic therapies are revolutionising severe asthma management, showcasing potential for remission, but cost and equitable access are the major barriers, according to a report on Tuesday. Biologic therapy, also known as immunotherapy, is a type of treatment that uses substances derived from living organisms to treat disease. The report by GlobalData, a data and analytics company, showed that the new Biologics target specific inflammatory pathways, shifting care from symptom con ...Read More >
VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it intends to complete a non-brokered private placement offering (the "Offering") consisting of up to an aggregate of 14,285,715 units of the Company (each, a "Unit") at a price of CAD$0.07 per Unit for gross proceeds of up to CAD$1,000,000. Each Unit consists of one (1) common share in the capital of the Company (each, a "Share") and one (1) wh ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.